MH3 COST-EFFECTIVENESS OF LONG-ACTING METHYLPHENIDATE FOR TREATMENT OF ATTENTIONDEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTS IN FINLAND- AN EVALUATION BASED UPON A RANDOMIZED CLINICAL TRIAL (RCT)
Abstract
Authors
M Schlander J Hjelmgren